rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study

Clinical trial NCT06137092 · COMPLETED

Trial details

NCT number: NCT06137092
Sponsor: AryoGen Pharmed Co.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2023-07-22
Primary completion: 2023-09-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.